Colorado MEDtech, CMED Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Colorado MEDtech, CMED

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: PaddyD who wrote (181)	2/2/1999 5:10:00 PM
From: Edward Larkin	Read Replies (1) of 288

Great numbers once again. This has been a normal ocurrence ever since Atanasoff and Arfman arrived at CMED. The company took a 1-2 cent charge to write off a small investment in a drug delivery company otherwise the numbers would have been 15-16 cents for the quarter, which sends a signal for next quarter. Also the gross margins on the incremental sales were sensational, boding for them to beat more estimates in the coming quarters. Atanasoff pointed to particularly strong latter half 99 prospects for biomed y2k sales, but it looked like they were already getting a boost from it this quarter. Way to go B-tub and Gino!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next